{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:09:06Z","timestamp":1784408946996,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,28]]},"DOI":"10.7759\/cureus.109808","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:03:18Z","timestamp":1779973398000},"source":"Crossref","is-referenced-by-count":1,"title":["Acute Myeloid Leukemia With Philadelphia Chromosome and Complex Karyotype: A Diagnostic Dilemma"],"prefix":"10.7759","author":[{"given":"Sandip","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabiha","family":"Modan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parloop A","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.348","article-title":"Mutations in AML: prognostic and therapeutic implications","volume":"2016","author":"DiNardo CD","year":"2016","unstructured":"DiNardo CD, Cortes JE. Mutations in AML: prognostic and therapeutic implications. Hematology Am Soc Hematol Educ Program. 2016, 2016:348-55. 10.1182\/asheducation-2016.1.348","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil E","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, et al.. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016, 374:2209-21. 10.1056\/NEJMoa1516192","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7335-21","article-title":"Acute megakaryoblastic leukemia harboring a subclone expressing BCR-ABL1 fusion gene product","volume":"60","author":"Kashima E","year":"2021","unstructured":"Kashima E, Nakano E, Watanabe Y, Imai H, Oka K, Kageyama S, Tanaka I. Acute megakaryoblastic leukemia harboring a subclone expressing BCR-ABL1 fusion gene product. Intern Med. 2021, 60:3609-14. 10.2169\/internalmedicine.7335-21","journal-title":"Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242015441","article-title":"Deciphering potential molecular signatures to differentiate acute myeloid leukemia (AML) with BCR::ABL1 from chronic myeloid leukemia (CML) in blast crisis","volume":"24","author":"Boucher L","year":"2023","unstructured":"Boucher L, Sorel N, Desterke C, et al.. Deciphering potential molecular signatures to differentiate acute myeloid leukemia (AML) with BCR::ABL1 from chronic myeloid leukemia (CML) in blast crisis. Int J Mol Sci. 2023, 24:15441. 10.3390\/ijms242015441","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber DA","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al.. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022, 140:1200-28. 10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.097832","article-title":"Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms","volume":"99","author":"Mughal TI","year":"2014","unstructured":"Mughal TI, Vannucchi AM, Soverini S, et al.. Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms. Haematologica. 2014, 99:797-801. 10.3324\/haematol.2013.097832","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1017\/pcm.2023.9","article-title":"Targeting BCR-ABL1-positive leukaemias: a review article","volume":"1","author":"Leak S","year":"2023","unstructured":"Leak S, Horne GA, Copland M. Targeting BCR-ABL1-positive leukaemias: a review article. Camb Prism Precis Med. 2023, 1:e21. 10.1017\/pcm.2023.9","journal-title":"Camb Prism Precis Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01069-9","article-title":"Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)\/BCR::ABL1. A DATAML registry study","volume":"14","author":"Gondran C","year":"2024","unstructured":"Gondran C, Dumas PY, B\u00e9rard E, et al.. Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)\/BCR::ABL1. A DATAML registry study. Blood Cancer J. 2024, 14:91. 10.1038\/s41408-024-01069-9","journal-title":"Blood Cancer J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.03.017","article-title":"Philadelphia chromosome-positive acute myeloid leukemia (Ph + AML) treated with imatinib mesylate (IM): a report with IM plasma concentration and bcr-abl transcripts","volume":"33","author":"Kondo T","year":"2009","unstructured":"Kondo T, Tasaka T, Sano F, et al.. Philadelphia chromosome-positive acute myeloid leukemia (Ph + AML) treated with imatinib mesylate (IM): a report with IM plasma concentration and bcr-abl transcripts. Leuk Res. 2009, 33:e137-8. 10.1016\/j.leukres.2009.03.017","journal-title":"Leuk Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2022.100333","article-title":"AML with BCR-ABL1 fusion treated with imatinib, a hypomethylating agent and venetoclax","volume":"17","author":"Low SK","year":"2022","unstructured":"Low SK, Nanua S, Patel M, Renteria AS. AML with BCR-ABL1 fusion treated with imatinib, a hypomethylating agent and venetoclax. Leuk Res Rep. 2022, 17:100333. 10.1016\/j.lrr.2022.100333","journal-title":"Leuk Res Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5265-5","article-title":"A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review","volume":"19","author":"Piedimonte M","year":"2019","unstructured":"Piedimonte M, Ottone T, Alfonso V, et al.. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review. BMC Cancer. 2019, 19:50. 10.1186\/s12885-019-5265-5","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd JC","year":"2002","unstructured":"Byrd JC, Mr\u00f3zek K, Dodge RK, et al.. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002, 100:4325-36. 10.1182\/blood-2002-03-0772","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494180-acute-myeloid-leukemia-with-philadelphia-chromosome-and-complex-karyotype-a-diagnostic-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:03:19Z","timestamp":1779973399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494180-acute-myeloid-leukemia-with-philadelphia-chromosome-and-complex-karyotype-a-diagnostic-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.109808","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}